A reduction in sirtuin-3 expression is evident in animal models of metabolic syndrome [228], HFpEF [6], and diabetic cardiomyopathy [229], signifying the importance of sirtuin-3 in disease. Here, SIRT3 is linked to diabetic cardiomyopathy.